Posts With Tag NASDAQ KNSA

Showing 1 - 2 of 2 Posts

Kiniksa Pharmaceuticals 8-K Report: Key Updates for Investors on Feb 21, 2025

•

Form 8-K

•

2025-02-25

Last updated: about 1 month ago

Kiniksa Pharmaceuticals 8-K Report: Key Updates for Investors on Feb 21, 2025

Explore Kiniksa Pharmaceuticals International's latest 8-K filing from February 21, 2025, highlighting significant corporate updates and share details for investors.

Kiniksa Pharmaceuticals biotechnology NASDAQ KNSA 8-K filing pharmaceuticals

Kiniksa Pharmaceuticals 8-K Report: Key Financial Insights as of January 13, 2025

•

Form 8-K

•

2025-01-13

Last updated: 4 months ago

Kiniksa Pharmaceuticals 8-K Report: Key Financial Insights as of January 13, 2025

Explore Kiniksa Pharmaceuticals' 8-K filing for January 13, 2025. Discover stock details, financial performance, and essential contact information for investors.

Kiniksa Pharmaceuticals Biotechnology NASDAQ KNSA Financial Reporting Pharmaceuticals Industry